Rambam AG Executives to Participate in BIO-Europe 2024 in Stockholm
Basel, Switzerland, October 5, 2024 — Rambam AG is pleased to announce that Sanja Tomovska, Chief Growth Officer, and Rouslan Michtchenko, Executive Director, will represent the company at BIO-Europe 2024 in Stockholm, Sweden, from November 4 to 6, 2024. BIO-Europe is Europe’s leading conference for biotech and life sciences sectors, bringing together top professionals from around the world for networking, collaboration, and partnership opportunities.
Located in the heart of the “Silicon Valley of biotech” - Basel, Switzerland, Rambam AG is a venture studio and a part of the Expert Systems accelerator platform for breakthrough drug discovery and development. With a strong presence in both US and European markets, Rambam’s participation in BIO-Europe highlights its continued commitment to driving innovation through strategic partnerships and cutting-edge science.
“We are excited to participate in BIO-Europe and connect with industry leaders who share our passion for advancing biotech innovation,” said Rouslan Michtchenko, Executive Director of Rambam AG. “We look forward to discussing the future of drug discovery and development, and how Rambam’s unique approach is helping to translate scientific insights into real-world therapies.”
About Rambam AG
Rambam AG is a Swiss-based venture studio and accelerator platform for breakthrough drug discovery and development. Rambam's programs are supported by a core group of seasoned industrial experts, program managers and dedicated functional area specialists in Europe (Switzerland, Netherlands, Portugal, Germany) and the US. Rambam brings to Europe a uniquely streamlined and agile operating model supported by smart early funding.
Contact:
Rouslan Michtchenko
rmichtchenko@rambam.ch